PostYou are now at: Home » Products » Health & Medical » Pharmaceutical »

CAS 14636-12-5 Terlipressin Acetate

Click image to view original image
Brand: YC
Price: 1.00USD/gram
Min.Order: 20 gram
Supply 10000 gram
Delivery: Shipment within 1 days since the date of payment
Address: China
Valid until: Never Expire
Updated on: 2018-01-14 19:41
Hits: 15
Buy
Company Detail
 
 
Details
 
Product Name:Terlipressin Acetate
Cas No.: 14636-12-5
EINECS: 238-680-8
Molecular Formula: C52H74N16O15S2
Molecular Weight: 1227.37
Purity (HPLC): 98.0%min.
Appearance: White powder
Single Impurity (HPLC): 1.0%max
Amino Acid Composition: ±10% of theoretical
Peptide Content (N%): >=80.0%
Water Content(Karl Fischer):>=10.0%
Specific Rotation (20/D): -95.0~-105.0°(c=1 1%HAc)
Acetate Content (HPIC): <=15.0%
MS(ESI): Consistent
Mass Balance: 95.0~105.0%
Grade : Pharmaceutical Grade
Storage: Closed, below 2 ~ 8℃ preservatio
Usage : Norepinephrine-resistant septic shock, bleeding esophageal varices, and for the complications of cirrhosis of the liver (esophageal and gastric variceal bleeding, ascites, liver and kidney syndrome) has important significance for the treatment of patients
 
Description:
 
Terlipressin (trade names Teripress by New Medicon Pharma and Glypressin by Ferring Pharmaceuticals) is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help.
Indications for use include norepinephrine-resistant septic shock and hepatorenal syndrome. In addition, it is used to treat bleeding esophageal varices.
Between the patients with cirrhosis of the liver into the portal circulation of each vein and venous congestion can occur in vascular anastomosis, portal vein pressure rise phenomenon. The most frequently appeared in the azygos vein anastomosis with lower esophageal varices, instant tube.
 
Total: 0 [Show All]  Related Reviews
 
More »Our Others Products

[ ProductsSearch ]  [ Add To Favourite ]  [ Tell Friends ]  [ Print Content ]  [ Violation Report ]  [ Close Window ]